Drug Eluting Stent Center

 TitlePublished DateAuthor(s)
Bioabsorbable Stents 
General Concepts 
News from Industry 
Other Drugs 
Biolimus Stent Performs Well in Long LesionsSeptember 28, 2009TCT Daily Staff
HORIZONS-AMI Substudies: Bivalirudin Benefits Vary Among Patient SubgroupsSeptember 28, 2009TCT Daily Staff
Two-Year Incidence of Stroke Low in SYNTAXSeptember 24, 2009TCT Daily Staff
Xience V Bests Taxus in SPIRIT IV, COMPARE TrialsSeptember 24, 2009TCT Daily Staff
ZEST Substudy: In-Segment Restenosis Rate Comparable for Taxus and EndeavorSeptember 24, 2009TCT Daily Staff
PROBI VIRI: Prolonged Bivalirudin Reduced Myocardial InjuryOctober 15, 2008tctmd
Since DES Introduction, Cardiovascular Medicare Costs DownOctober 15, 2008tctmd
ZEST-AMI: 12-Month MACE Similar Between Different DES in STEMIOctober 15, 2008tctmd
DES, CABG Comparable for Death, MI in Left Main DiseaseOctober 14, 2008tctmd
FAME: One-Year ResultsOctober 14, 2008TCT Daily Staff
SYNTAX: Stenting vs. Surgery in Left Main and Triple Vessel DiseaseOctober 14, 2008tctmd
Triple Antiplatelet Therapy Reduced Thrombosis, MI Rates After DESOctober 14, 2008tctmd
Lower Cerebrovascular Events, Death, MI, with DES vs. CABG in Left Main DiseaseOctober 13, 2008tctmd
AHA Statement on Cocaine-Associated Chest Pain: Avoid Beta Blockers, DESMarch 17, 2008Kim Dalton
OrbusNeich's Genous(TM) Bio-engineered R Stent(TM) has Lower MACE Rate than TAXUS(R) and CYPHER(R) Stents in Clinical TrialJanuary 10, 2008 
FDA Advisory Committee Recommends Approval of Abbott's XIENCE™ V Drug Eluting Stent SystemNovember 29, 2007 
Abbott to Present Comprehensive Safety and Efficacy Data on XIENCE™ V Drug Eluting Stent to FDA Advisory Committee on November 29November 27, 2007 
Stent Thrombosis After Implantation of Drug-Eluting or Bare Metal Coronary Stents in Western DenmarkMarch 26, 2007Michael Maeng
Randomized Comparison of the Effect of Distal Protection and Drug Eluting Stent vs. Bare Metal Stent Implantation during PCI for ST-Elevation MI (DEDICATION)March 25, 2007Leif Thuesen
SESAMI Update and First Presentation of Restenosis Analysis and Cost-Effectiveness AnalysisOctober 26, 2006Maurizio Menichelli